Clinical Trials Logo

Apnea Syndrome clinical trials

View clinical trials related to Apnea Syndrome.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05908188 Recruiting - Clinical trials for Obstructive Sleep Apnea

Analysis of Mandibular Movements in Ventilated Children With Sleep Apnea Syndrome

AMANDA
Start date: February 15, 2023
Phase:
Study type: Observational

Obstructive Sleep Apnea is a common medical condition in children. Diagnosis is based on polysomnography . We conducted an open prospective non randomised clinical trial to assess the efficacy of a new medical device called SUNRISE.

NCT ID: NCT04606693 Recruiting - Clinical trials for Atrial Fibrillation, Persistent

Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates

SLEEP-AF
Start date: November 5, 2020
Phase: N/A
Study type: Interventional

The present prospective cohort study (not randomized) analyses the value of screening and treatment of SAHS in the management of patients with AF refractory to antiarrhythmics drugs, potentially candidates for ablation. Patients at low risk of suffering from SAHS will follow conventional management of their AF, according to the usual criteria of the Arrhythmia Unit. Patients with high or intermediate risk of SAHS, will undergo respiratory polygraphy. If the result is positive, they will be treated as standard for this syndrome and their heart rate will be monitored for 3 months. After this, the patient's arrhythmic load will be reevaluated differentiating patients into two groups, those that must be ablated from those that have improved their condition and the clinical criteria is no longer ablation but follow-up.

NCT ID: NCT04474756 Recruiting - Apnea Syndrome Clinical Trials

Comparison of Efficacy of Two Mandibular Advancement Devices (MADs) During Sleep

SONAR
Start date: June 15, 2020
Phase: N/A
Study type: Interventional

Mandibular Advancement Devices (MADs) are now a reliable alternative to continuous positive airway pressure (CPAP) treatments for Obstructive Sleep Apnea (OSA) . Despite good tolerance and efficacy, there are still barriers limiting the widespread use of MAD and its acceptance in OSA routine clinical practice. Various MAD designs currently exist and constantly emerge on the market without clear evidence regarding the best technical choice and the cost-effectiveness compromise. Although these MAD has been tested in term of efficacy, no study has tested the difference between MADs in term of efficacy, tolerance and patient satisfaction. The aim of this clinical trial is to compare the effectiveness of two MADs - custom-made titratable MAD (NarvalTM) and customizable titratable MAD (TALITM), over a 3-month period, in patients with obstructive sleep apnea (OSA).